Technologies

Medical Sciences

Title:

Immunoassay based blood test for detection of Alzheimer’s disease (AD) using plasmonic - fibre optics absorbance biosensor platform (P-FAB)

Area:

Medical Sciences

Focus Area:

Molecular Biology, Frugal Innovation

Status:

Proof of Concept established

Patent:

IP Status: In process (Immunoassay for the detection of AD)

Social Benefits:

The product intends to reduce the healthcare burden and improve the quality of life for individuals affected by Alzheimer’s disease.

Developing Agency:

Healthiverse Wellness Private Limited, Tamil Nadu

Technology Readiness Index:

TRL 3

Source Title:

Data sourced from Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT)

Brief Description

Description :

The immunoassay-based blood test for detecting Alzheimer’s disease (AD) utilizes the Plasmonic-Fiber Optic Absorbance Biosensor Platform (P-FAB). Addressing the need for a sensitive assay to detect changes in the concentration of the Alzheimer's disease biomarker, Amyloid β 42, the P-FAB platform employs a sandwich assay approach with plasmonic labels on a U-bent fiber optic sensor probe. Effectively measuring biomarker concentrations in pg/ml, P-FAB presents a promising solution for accurate Alzheimer’s disease detection.

Related Technologies